Trade

Watchlist

Portfolio

Message

Set Alert

BSE LIVE NSE LIVE 26 Aug, 2025 12:21 Volume Todays L/H More ×

Anand Rathi's research report on Sumitomo Chemicals

Below consensus and as we estimated, Sumitomo’s Q2 was weak; revenue/EBITDA/PAT fell 6/11/8% y/y. Key highlights: a) Domestic revenue down 4% y/y to Rs7.7bn; exports down 13% y/y to Rs1.6bn. b) Exports subdued due to Europe, Japan and LATAM revenues down 53/13/38% y/y. c) Asia/Africa revenues were Rs186m/279m, up 64/31% y/y. d) The GM expanded 60bps y/y to 43.1% on the stable pricing environment, offset by lower volumes. e) higher GMs were fully offset by inferior operating leverage (employee cost up 80bps y/y; opex up 110bps y/y) leading to the EBITDA margin contracting 140bps y/y to 23.4%. f) Specialty/g

See Full Page